PrP(106-126) does not interact with membranes under physiological conditions

被引:72
作者
Henriques, Sonia Troeira [1 ]
Pattenden, Leonard Keith [2 ]
Aguilar, Marie-Isabel [2 ]
Castanho, Miguel A. R. B. [1 ]
机构
[1] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal
[2] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
基金
澳大利亚研究理事会;
关键词
D O I
10.1529/biophysj.108.131458
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Transmissible spongiform encephalopathies are neurodegenerative diseases characterized by the accumulation of an abnormal isoform of the prion protein PrPSc. Its fragment 106-126 has been reported to maintain most of the pathological features of PrPSc, and a role in neurodegeneration has been proposed based on the modulation of membrane properties and channel formation. The ability of PrPSc to modulate membranes and/ or form channels in membranes has not been clearly demonstrated; however, if these processes are important, peptide-membrane interactions would be a key feature in the toxicity of PrPSc. In this work, the interaction of PrP(106-126) with model membranes comprising typical lipid identities, as well as more specialized lipids such as phosphatidylserine and GM1 ganglioside, was examined using surface plasmon resonance and fluorescence methodologies. This comprehensive study examines different parameters relevant to characterization of peptide-membrane interactions, including membrane charge, viscosity, lipid composition, pH, and ionic strength. We report that PrP(106-126) has a low affinity for lipid membranes under physiological conditions without evidence of membrane disturbances. Membrane insertion and leakage occur only under conditions in which strong electrostatic interactions operate. These results support the hypothesis that the physiological prion protein PrPC mediates PrP(106-126) toxic effects in neuronal cells.
引用
收藏
页码:1877 / 1889
页数:13
相关论文
共 69 条
[31]   Interactions of amyloid β-protein with various gangliosides in raft-like membranes:: Importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid [J].
Kakio, A ;
Nishimoto, S ;
Yanagisawa, K ;
Kozutsumi, Y ;
Matsuzaki, K .
BIOCHEMISTRY, 2002, 41 (23) :7385-7390
[32]   Studies on the membrane interactions of the cyclotides kalata B1 and kalata B6 on model membrane systems by surface plasmon resonance [J].
Kamimori, H ;
Hall, K ;
Craik, DJ ;
Aguilar, MI .
ANALYTICAL BIOCHEMISTRY, 2005, 337 (01) :149-153
[33]   Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization [J].
Kazlauskaite, J ;
Sanghera, N ;
Sylvester, I ;
Vénien-Bryan, C ;
Pinheiro, TJT .
BIOCHEMISTRY, 2003, 42 (11) :3295-3304
[34]   Formation of supported membranes from vesicles [J].
Keller, CA ;
Glasmästar, K ;
Zhdanov, VP ;
Kasemo, B .
PHYSICAL REVIEW LETTERS, 2000, 84 (23) :5443-5446
[35]   Quantifying amyloid β-peptide (Aβ) aggregation using the Congo red Aβ (CR-Aβ) spectrophotometric assay [J].
Klunk, WE ;
Jacob, RF ;
Mason, RP .
ANALYTICAL BIOCHEMISTRY, 1999, 266 (01) :66-76
[36]   Mechanisms of prion-induced modifications in membrane transport properties: Implications for signal transduction and neurotoxicity [J].
Kourie, JI .
CHEMICO-BIOLOGICAL INTERACTIONS, 2001, 138 (01) :1-26
[37]  
Kourie JI, 2000, J NEUROSCI RES, V62, P120, DOI 10.1002/1097-4547(20001001)62:1<120::AID-JNR13>3.0.CO
[38]  
2-2
[39]   Neurotoxicity of prion peptide 106-126 not confirmed [J].
Kunz, B ;
Sandmeier, E ;
Christen, P .
FEBS LETTERS, 1999, 458 (01) :65-68
[40]   How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? [J].
Ladokhin, AS ;
Jayasinghe, S ;
White, SH .
ANALYTICAL BIOCHEMISTRY, 2000, 285 (02) :235-245